Vladimir Torchilin
Corporate Officer/Principal chez Northeastern University
Fortune : 3 M $ au 31/03/2024
Profil
Vladimir Torchilin is the founder of Nemucore Medical Innovations, Inc. (founded in 2008) and Immix Biopharma, Inc. (founded in 2012).
He is currently the Director of Pharmaceutical Biotechnology and a Professor at Northeastern University since 1998.
Dr. Torchilin's former positions include being the Head of Chemistry Program at The General Hospital Corp.
(1993-1997) and an Associate Professor at Harvard Medical School (1993-1997).
Dr. Torchilin received his graduate and doctorate degrees from Moscow State University Lomonosov.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMIX BIOPHARMA, INC.
3,54% | 14/04/2023 | 905 200 ( 3,54% ) | 3 M $ | 31/03/2024 |
Postes actifs de Vladimir Torchilin
| Sociétés | Poste | Début |
|---|---|---|
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | Corporate Officer/Principal | 01/01/1998 |
Anciens postes connus de Vladimir Torchilin
| Sociétés | Poste | Fin |
|---|---|---|
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/1997 |
| Harvard Medical School | Corporate Officer/Principal | 01/01/1997 |
| IMMIX BIOPHARMA, INC. | Founder | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Founder | - |
Formation de Vladimir Torchilin
| Moscow State University Lomonosov | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMIX BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
